These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
139 related articles for article (PubMed ID: 11346681)
1. Docetaxel and herceptin: foundation for future strategies. Pegram MD Oncologist; 2001; 6 Suppl 3():22-5. PubMed ID: 11346681 [TBL] [Abstract][Full Text] [Related]
2. Trials of new combinations of Herceptin in metastatic breast cancer. Thomssen C Anticancer Drugs; 2001 Dec; 12 Suppl 4():S19-25. PubMed ID: 11989523 [TBL] [Abstract][Full Text] [Related]
3. Rationale for trastuzumab (Herceptin) in adjuvant breast cancer trials. Slamon D; Pegram M Semin Oncol; 2001 Feb; 28(1 Suppl 3):13-9. PubMed ID: 11301370 [TBL] [Abstract][Full Text] [Related]
5. Docetaxel (Taxotere) plus trastuzumab (Herceptin) in breast cancer. Burris HA Semin Oncol; 2001 Feb; 28(1 Suppl 3):38-44. PubMed ID: 11301373 [TBL] [Abstract][Full Text] [Related]
6. Docetaxel (Taxotere) in HER-2-positive patients and in combination with trastuzumab (Herceptin). Burris HA Semin Oncol; 2000 Apr; 27(2 Suppl 3):19-23. PubMed ID: 10810934 [TBL] [Abstract][Full Text] [Related]
7. The platinum agents: a role in breast cancer treatment? Crown JP Semin Oncol; 2001 Feb; 28(1 Suppl 3):28-37. PubMed ID: 11301372 [TBL] [Abstract][Full Text] [Related]
8. The effect of trastuzumab/docatexel combination on breast cancer angiogenesis: dichotomus effect predictable by the HIFI alpha/VEGF pre-treatment status? Koukourakis MI; Simopoulos C; Polychronidis A; Perente S; Botaitis S; Giatromanolaki A; Sivridis E Anticancer Res; 2003; 23(2C):1673-80. PubMed ID: 12820439 [TBL] [Abstract][Full Text] [Related]
9. Platinum-taxane combinations in metastatic breast cancer: an evolving role in the era of molecularly targeted therapy. Crown J; Pegram M Breast Cancer Res Treat; 2003; 79 Suppl 1():S11-8. PubMed ID: 12868801 [TBL] [Abstract][Full Text] [Related]
10. Clinical efficacy of taxane-trastuzumab combination regimens for HER-2-positive metastatic breast cancer. Bullock K; Blackwell K Oncologist; 2008 May; 13(5):515-25. PubMed ID: 18515736 [TBL] [Abstract][Full Text] [Related]
11. In vitro comparative evaluation of trastuzumab (Herceptin) combined with paclitaxel (Taxol) or docetaxel (Taxotere) in HER2-expressing human breast cancer cell lines. Merlin JL; Barberi-Heyob M; Bachmann N Ann Oncol; 2002 Nov; 13(11):1743-8. PubMed ID: 12419746 [TBL] [Abstract][Full Text] [Related]
12. Phase II study of weekly docetaxel and trastuzumab for patients with HER-2-overexpressing metastatic breast cancer. Esteva FJ; Valero V; Booser D; Guerra LT; Murray JL; Pusztai L; Cristofanilli M; Arun B; Esmaeli B; Fritsche HA; Sneige N; Smith TL; Hortobagyi GN J Clin Oncol; 2002 Apr; 20(7):1800-8. PubMed ID: 11919237 [TBL] [Abstract][Full Text] [Related]
13. Herceptin alone or in combination with chemotherapy in the treatment of HER2-positive metastatic breast cancer: pivotal trials. Baselga J Oncology; 2001; 61 Suppl 2():14-21. PubMed ID: 11694783 [TBL] [Abstract][Full Text] [Related]
14. Docetaxel in the adjuvant therapy of HER-2 positive breast cancer patients. Vici P; Viola G; Botti C; Rossi S; Vitucci C; Corsetti S; Di Lauro L; Sergi D; Foggi P; Perri P; Tirelli C; Mottolese M; Fattoruso SI; Lopez M Clin Ter; 2008; 159(6):449-52. PubMed ID: 19169607 [TBL] [Abstract][Full Text] [Related]
15. The current status of docetaxel for metastatic breast cancer. Esteva FJ Oncology (Williston Park); 2002 Jun; 16(6 Suppl 6):17-26. PubMed ID: 12108894 [TBL] [Abstract][Full Text] [Related]
16. Recent progress in the clinical development of docetaxel (Taxotere). Hortobagyi GN Semin Oncol; 1999 Jun; 26(3 Suppl 9):32-6. PubMed ID: 10426457 [TBL] [Abstract][Full Text] [Related]
17. Moving forward: Herceptin in the adjuvant setting. Tan-Chiu E; Piccart M Oncology; 2002; 63 Suppl 1():57-63. PubMed ID: 12422056 [TBL] [Abstract][Full Text] [Related]
18. Results of two open-label, multicenter phase II studies of docetaxel, platinum salts, and trastuzumab in HER2-positive advanced breast cancer. Pegram MD; Pienkowski T; Northfelt DW; Eiermann W; Patel R; Fumoleau P; Quan E; Crown J; Toppmeyer D; Smylie M; Riva A; Blitz S; Press MF; Reese D; Lindsay MA; Slamon DJ J Natl Cancer Inst; 2004 May; 96(10):759-69. PubMed ID: 15150304 [TBL] [Abstract][Full Text] [Related]
19. [Docetaxel (Taxotere) in combination with trastuzumab (Herceptin)]. Ficorella C Tumori; 2001; 87(1 Suppl 2):S10-8. PubMed ID: 11357872 [No Abstract] [Full Text] [Related]
20. Role of Herceptin in primary breast cancer: views from North America and Europe. Leyland-Jones B; Smith I Oncology; 2001; 61 Suppl 2():83-91. PubMed ID: 11694792 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]